technetium-99m

technetium-99m is a metastable nuclear isomer of technetium-99 that serves as the cornerstone of modern diagnostic nuclear medicine. Its widespread use stems from its nearly ideal physical and chemical properties, including a short half-life, pure gamma ray emission, and the ability to form a variety of useful radiopharmaceuticals. Discovered in 1938 by Emilio Segrè and Carlo Perrier, its medical potential was realized in the 1960s, revolutionizing non-invasive imaging. Today, it is involved in over 80% of all diagnostic nuclear medicine procedures worldwide, making it one of the most important medical isotopes.

Properties

Technetium-99m decays via isomeric transition to its ground state, technetium-99, emitting a monoenergetic gamma ray with an energy of 140.5 keV. This energy is nearly ideal for detection by gamma cameras, as it is high enough to escape the body with minimal attenuation but low enough to be efficiently captured by sodium iodide or cadmium zinc telluride detectors. Its half-life of approximately six hours is long enough to permit complex radiopharmaceutical preparation and imaging procedures, yet short enough to minimize the radiation dose to the patient. The decay product, technetium-99, has a very long half-life and undergoes beta decay to stable ruthenium-99.

Production

The primary method of production is via the beta decay of its parent isotope, molybdenum-99, in a device known as a technetium-99m generator or "moly cow". Molybdenum-99 itself is primarily produced by the neutron irradiation of uranium-235 targets in high-flux research reactors, such as the National Research Universal Reactor in Canada, the High Flux Reactor in the Netherlands, and the BR2 reactor in Belgium. The fission of uranium-235 yields molybdenum-99, which is then chemically processed and loaded onto a generator column. Due to the short half-life of molybdenum-99, a global supply chain involving entities like the International Atomic Energy Agency and producers such as Curium is critical.

Medical applications

Technetium-99m is the most commonly used medical radioisotope for single-photon emission computed tomography (SPECT) imaging. Its applications span nearly every organ system, providing functional and metabolic information complementary to anatomical studies from computed tomography or magnetic resonance imaging. Key imaging procedures include myocardial perfusion imaging for assessing coronary artery disease, bone scintigraphy for detecting metastases or osteomyelitis, renal scintigraphy for evaluating kidney function, and ventilation/perfusion scans for diagnosing pulmonary embolism. It is also used in sentinel lymph node mapping for cancers like breast cancer and melanoma.

Radiopharmaceuticals

The utility of technetium-99m lies in its versatile chemistry, allowing it to be bound to various pharmaceutical compounds that target specific physiological processes. The reduced form, technetium(VII) as pertechnetate, is used for thyroid and Meckel's diverticulum imaging. More commonly, it is complexed with ligands, such as sestamibi for cardiac studies, methylenediphosphonate for bone scans, and mercaptoacetyltriglycine for renal imaging. These kits, often developed by companies like GE Healthcare and Bracco Diagnostics, are supplied as sterile, lyophilized formulations to which sodium pertechnetate is added.

Safety and handling

Handling of technetium-99m is governed by strict ALARA principle guidelines to minimize radiation exposure to medical staff, patients, and the public. Its short half-life means that radioactive waste decays to manageable levels relatively quickly. However, the long-lived decay product, technetium-99, presents an environmental consideration for waste disposal. In a medical setting, shielding with lead or tungsten, proper personal protective equipment, and monitoring with devices like Geiger counters are standard. Regulatory bodies like the U.S. Nuclear Regulatory Commission and the Radioactive Materials Committee oversee its use and transport.

Category:Technetium Category:Medical isotopes Category:Nuclear medicine